Annexon ANNX
NASDAQ ANNX
$4.86 +0.02 (+0.52%)
As of: Sep 4, 2026 · 2:34 PM EDT

Annexon (ANNX) Change in Account Payables (2019 - 2026)

Annexon (ANNX) posted quarterly Change in Account Payables of $2.2 million for Q1 2026, up 7038.71% year-over-year from $30131.5 in Q1 2025, and up 165.88% quarter-over-quarter from -$3.3 million in Q4 2025.

Analysis

Annexon (ANNX) Change in Account Payables (2019 - 2026) Analysis & Trends

Annexon's Change in Account Payables history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 7038.71% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $6.7 million (up 3.68% YoY), while the FY2025 annual figure was $4.5 million, down 9.02% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $2.2 million, up from -$3.3 million in the prior quarter.
  • The five-year high for Change in Account Payables was $6.7 million in Q3 2025, with the low at -$3.4 million in Q3 2022.
  • The 5-year median for Change in Account Payables is $490000.0 (2022), against an average of $542000.0.
  • The sharpest annual moves came in 2022 and 2026: Change in Account Payables tumbled 514.18% in 2022, then soared 7038.71% in 2026.
  • Annexon's Change in Account Payables stood at $490000.0 in 2022, then slipped by 13.06% to $426000.0 in 2023, then jumped by 765.96% to $3.7 million in 2024, then plunged by 188.51% to -$3.3 million in 2025, then jumped by 165.88% to $2.2 million in 2026.
  • Business Quant data shows ANNX's Change in Account Payables at $2.2 million in Q1 2026, -$3.3 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 5.03 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Annexon 977.88 Mn 977.88 Mn - -1.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.36 Mn
Mar 31, 2026 2.15 Mn
Dec 31, 2025 -3.27 Mn
Sep 30, 2025 6.67 Mn
Jun 30, 2025 1.12 Mn
Mar 31, 2025 -31,000.00
Dec 31, 2024 3.69 Mn
Sep 30, 2024 2.70 Mn
Jun 30, 2024 74,000.00
Mar 31, 2024 -1.53 Mn
Dec 31, 2023 426,000.00
Sep 30, 2023 -2.35 Mn
Jun 30, 2023 -3.19 Mn
Mar 31, 2023 3.04 Mn
Dec 31, 2022 490,000.00
Sep 30, 2022 -3.45 Mn
Jun 30, 2022 884,000.00
Mar 31, 2022 1.79 Mn
Dec 31, 2021 2.99 Mn
Sep 30, 2021 832,000.00